StockData

Jyong Biotech Ltd. (MENS) stock

MENSNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 0/30
$1.75−0.11 (-5.91%)

Close on Nov 19, 2026Market cap $133.05MP/E –Yield –

Jyong Biotech pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Jyong Biotech

Jyong Biotech has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Jyong Biotech figures

See a number that looks wrong?